Resources

View our sample template for the new single Medicinal cannabis licence.

View our sample template for the medicinal cannabis permit for manufacture.

Use this template to report sales of kava food products if you import kava for food use in Australia.

Application form for a medicinal cannabis permit – cultivation and production.

Information for applicants who intend to apply for a medicinal cannabis permit for medicinal or scientific purposes – cultivation and production activities.

User guide for applying for a medicinal cannabis manufacture permit, including application requirements, supporting information and key steps.

Medicinal cannabis products must meet quality standards under Therapeutic Goods Order No. 93, whether imported or manufactured in Australia.

The ODC business plan January–June 2022 details regulatory reform, medicinal cannabis licensing changes, compliance priorities and kava pilot activities.

The Narcotic Drugs Act 1967 gives effect to some of Australia’s obligations under the Single Convention on Narcotic Drugs, 1961.

Regulation outlining licence charges for medicinal cannabis and cannabis research licences under the Narcotic Drugs (Licence Charges) Act.

Learn how cost recovery supported the regulation of Australia's Medicinal Cannabis Scheme in 2020–21, including fees, performance reporting and financial forecasts.

Learn how cost recovery supports the regulation of Australia's Medicinal Cannabis Scheme, including fees, performance reporting and financial forecasts.

Presentation slides from the medicinal cannabis single licence reform information session held on 13 October 2021.

Guidance on testing medicinal cannabis, cannabis resin and cannabis products, including laboratory requirements, record keeping and third-party testing services.

The Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021 introduced a requirement for a review of the medicinal cannabis scheme to be undertaken.

Australian Government response to the Senate inquiry into the Regulator of Medicinal Cannabis Bill 2014 and the development of Australia's medicinal cannabis framework.

The Australian Government response to the Inquiry into current barriers to patient access to medicinal cannabis has now been published.

Read the Kava Pilot Phase 2 consultation paper on proposed commercial importation arrangements and provide feedback on the future of kava access in Australia.

Presentation slides from the Kava Pilot Phase 2 Design webinar, covering proposed reforms for commercial kava importation and stakeholder consultation.

Guidance to help medicinal cannabis licence applicants and holders meet security requirements for the cultivation, production and manufacture of cannabis.

Overview of how ODC recovers costs for regulating medicinal cannabis, including application processing, monitoring and compliance activities.

Use this form to authorise the Office of Drug Control (ODC) to obtain information about a person named in an application for the grant or variation of a licence under the Narcotic Drugs Act 1967.

Review of the Medicinal Cannabis Cost Recovery Framework (2019–2020), outlining findings and recommendations for regulatory cost recovery.

Government consultation on proposed reforms to introduce a single medicinal cannabis licence and streamline the application process under the Narcotic Drugs Act.

Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years.